Haass_Melanoma_lab
@HaassLab
Followers
879
Following
3K
Media
163
Statuses
870
Understanding the biology of melanoma heterogeneity with a goal to improve therapies. #tumor_spheroids #microscopy #scitweets #FUCCI
Australia
Joined August 2018
Hot off the press! Congrats to Sanket, @LukeJohnsonLab and their team and collaborators - fantastic work! Raut SB, Joly F, Haass NK, Eri R, Canales JJ, Benedek DM, Ursano RS, Johnson LR (2024). Transl Psychiatry 14: 492 doi:
nature.com
Translational Psychiatry - The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD models
0
0
1
NHMRC results are out "Under Embargo". Yes we know that the Australian Government is only interested in mining and footy, but not in science and the arts. So, why Embargo?!
0
0
3
Do you remember the four years (Jan 2017-Jan 2021) of chaos, destruction and disaster? Not again! If you love democracy, unity, human rights, peace and our precious environment, please vote for Kamala Harris!
This video is incredible. Everyone should RETWEET it so the whole *world* sees it.
0
0
1
Today!
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/UlASGg3aFD
@MelanomaAus
0
0
10
TRI explored melanoma, the immune system, prostate, bladder and childhood brain cancer - as part of a mini-symposium today. Thanks Dr Mitchell Lawrence at @MonashUni, @srilakshmisri13, @HaassLab, Elysse Morris, Dr Liam O'Brien, @OzEDW, @BockNat. @QUT, @UQ_News, @MaterResearch.
0
1
8
Long week: #FrazerInstUQ @UQMedicine HDR retreat on Monday and Tuesday on Minjerribah, and Skin Cancer 2024 conference from Wednesday through to Sunday at the BCEC! https://t.co/yZC3nEprwp
0
0
7
🎁Interested in reading more about the study? Here is the Research Briefing describing the authors' and an expert's view, but also the editor's perspective on the findings and their importance. #microtubule #mechanobiology 👉🏽 https://t.co/eMenKJilVb
https://t.co/NN6ip7FEdx
nature.com
Nature Cell Biology - In cells migrating through complex three-dimensional microenvironments, microtubules are adaptively reinforced at areas of high compressive stress. This reinforcement controls...
0
2
10
💫NEW: @SamStehbens, @robertr33 & co show that during 3D #CellMigration, compression recruits cytoplasmic linker-associated proteins to #microtubules, which coordinate nuclear positioning and contractility in confined migration. 👉🏼 https://t.co/zIlv03XDSm
https://t.co/2dROizX00c
0
0
2
IUBP-MEPSA World Congress, 25th-30th August 2024, Perth. We certainly cannot say that we didn't know better back then.
0
1
1
Team science wins again. This project epitomises what can be achieved when the right group of people are proud together. Huge congratulations to @MelanomaACEMID team!!
🏆 ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis @MelanomaACEMID @UQMedicine is awarded the @BizEventsPerth Eureka Prize for Excellence in Interdisciplinary Scientific Research. #EurekaPrizes Learn more: https://t.co/X97S4t6u4A
0
4
30
IUBP-MEPSA World Congress 2024, Perth. Session "Melanoma heterogeneity and therapeutic approaches" on the 27th August 2024. @TheStarkLab, #FrazerInstUQ, @UQMedicine; @vivianchualah, @EdithCowanUni; Peter Lau, @PerkinsComms; @HaassLab, #FrazerInstUQ, @UQMedicine
0
0
5
#FrazerInstUQ @UQMedicine HDR Minisymposium today. Great talks, great discussion. People's choice best talk award goes to Marion Barros @SimpsonTeamUQ. Runner-up was Daniel Butcher @YUmmunology. Congratulations!
0
0
13
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/UlASGg3aFD
@MelanomaAus
0
1
8
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: https://t.co/BSg1QNF0SI
@MelanomaAus
0
1
7
Great talk by A/Prof Aideen McInerney-Leo, from UQ, about the importance of Mainstreaming Melanoma Genetic Testing in Australia. @Amcinerneyleo @AsdrResearch @CTSR_USyd
0
5
13
Prof @DrJonasANilsson, Keynote Speaker at the ASDR2024 Session 6, talking about cell therapy for therapy-resistant metastatic melanoma. @AsdrResearch @CTSR_USyd
0
1
3
Former @AsdrResearch president Prof Nikolas Haass gave the prestigious Ross Barnetson Lecture @AsdrResearch #ASDR2024 👏👏👏👏👏👏👏👏👏👏👏👏👏
0
2
12
The sun is rising over ASDR2024. It’s going to be an exciting few days here @WestmeadHub @WestmeadInst for Dermatology research @AsdrResearch. It’s all about to begin!
0
6
25
Great job! Thank you so much for organising this amazing conference!
#ASDR2024 hardworking registration desk staff members (except me). What a great event so far! Full of talks, collaborations, sponsors, and food. @AsdrResearch @CTSR_USyd
0
0
4
Day 1 at the Australasian Society for Dermatology #research conference was fantastic! Inspiring talks, great poster presentations, networking & exciting new discoveries. A great start to an amazing event! Looking forward to Day 2 @AsdrResearch
0
3
10